Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("busulfan")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 999

  • Page / 40
Export

Selection :

  • and

STUDIES ON THE CYTOTOXICITY OF MYLERAN AND DIMETHYL MYLERANMITCHELL MP; WALKER IG.1972; CANAD. J. BIOCHEM.; CANADA; DA. 1972; VOL. 50; NO 10; PP. 1074-1081; ABS. FR.; BIBL. 18REF.Serial Issue

TOXICITY OF BUSULFAN AND INFLUENCE CHEMOSTERILIZED BOLL WEEVILS ON REPRODUCTIVE PERFORMANCE OF THE JAPANESE QUAIL = LA TOXICITE DU BUSULFAN ET L'INFLUENCE DE L'INGESTION D'ANTHONOMUS GRANIDIS STERILISE SUR LA CAPACITE DE REPRODUCTION DE COTURNIX COTURNIX JAPONICAKULKARNI PG; MITLIN N; HURST GA et al.1973; J. ECON. ENTOMOL.; U.S.A.; DA. 1973; VOL. 66; NO 2; PP. 341-343; BIBL. 13 REF.Serial Issue

Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan : reduced toxicity without the need for pharmacokinetic monitoringMAMLOUK, K; SARACINO, G; BERRYMAN, R. B et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 8, pp 747-754, issn 0268-3369, 8 p.Article

Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adultsDIESTELHORST, Christian; BOOS, Joachim; MCCUNE, Jeannine S et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 5, pp 991-1000, issn 0344-5704, 10 p.Article

An Automated Method for Supporting Busulfan Therapeutic Drug MonitoringJUENKE, Joetta M; MILLER, Kendall A; MCMILLIN, Gwendolyn A et al.Therapeutic drug monitoring. 2011, Vol 33, Num 3, pp 315-320, issn 0163-4356, 6 p.Article

Busulfan-induced apoptosis in rat placentaFURUKAWA, Satoshi; USUDA, Koji; ABE, Masayoshi et al.Experimental and toxicologic pathology (Print). 2007, Vol 59, Num 2, pp 97-103, issn 0940-2993, 7 p.Article

Population pharmacokinetics of oral busulfan in childrenSCHILTMEYER, Brunhild; KLINGEBIEL, Thomas; HEMPEL, Georg et al.Cancer chemotherapy and pharmacology. 2003, Vol 52, Num 3, pp 209-216, issn 0344-5704, 8 p.Article

Intérêt clinique de l'adaptation des posologies du busulfan et de la ciclosporine chez des enfants greffés de moelle osseuse = Busulfan and cycosporin in bone graft childrenBERTOLLE, V; MARTIN, P; BLEYZAC, N et al.Annales pharmaceutiques françaises. 2004, Vol 62, Num 3, pp 165-176, issn 0003-4509, 12 p.Article

High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical productsBOULIGAND, Jérome; PACI, Angelo; MERCIER, Lionel et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 34, Num 3, pp 525-530, issn 0731-7085, 6 p.Article

MATING AND STERILITY OF MALE BOLL WEEVILS TREATED WITH BUSULFAN PLUS HEMPA = ACCOUPLEMENT ET STERILITE DES ANTHONOMES MALES TRAITES AU BUSULFAN ADDITIONNE DE HEMPAHAYNES JW; MITLIN N; DAVICH TB et al.1975; ENVIRONMENT. ENTOMOL.; U.S.A.; DA. 1975; VOL. 4; NO 2; PP. 315-318; BIBL. 15 REF.Article

Accidental busulfan overdose during conditioning for stem cell transplantationJENKE, A; FREIBERG-RICHTER, J; WILHELM, S et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 2, pp 125-128, issn 0268-3369, 4 p.Article

I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipientsNGUYEN, L; FULLER, D; LENNON, S et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 10, pp 979-987, issn 0268-3369, 9 p.Article

UNERWUENSCHTE NEBENWIRKUNGEN VON BUSULFAN = EFFETS SECONDAIRES NON DESIRES DU BUSULFANJAPP H.1974; DTSCH. MED. WSCHR.; DTSCH.; DA. 1974; VOL. 99; NO 51; PP. 2614-2615; BIBL. 10REF.Article

Integration of modelling and simulation into the development of intravenous busulfan in paediatrics : an industrial experienceNGUYEN, L.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 599-604, issn 0767-3981, 6 p.Conference Paper

Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablationVENG-PEDERSEN, P; CHAPEL, S; AL-HUNITI, N. H et al.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 4, pp 149-156, issn 0142-2782, 8 p.Article

The use of pharmacokinetic models in paediatric onco-haematology : effects on clinical outcome through the examples of busulfan and cyclosporineBLEYZAC, N.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 605-608, issn 0767-3981, 4 p.Conference Paper

Busulphan-loaded long-circulating nanospheres, a very attractive challenge for both galenists and pharmacologistsBOULIGAND, Jerome; COUVREUR, Patrick; LAYRE, Anne M et al.Journal of microencapsulation. 2007, Vol 24, Num 8, pp 715-730, issn 0265-2048, 16 p.Article

Repetitive Busulfan Administration After Hematopoietic Stem Cell Gene Therapy Associated with a Dominant HDAC7 Clone in a Nonhuman PrimateJIANJUN XIE; LAROCHELLE, Andre; MARIC, Irina et al.Human gene therapy. 2010, Vol 21, Num 6, pp 695-703, issn 1043-0342, 9 p.Article

DNA intrastrand cross-link at the 5'-GA-3' sequence formed by busulfan and its role in the cytotoxic effectIWAMOTO, Takuya; HIRAKU, Yusuke; OIKAWA, Shinji et al.Cancer science. 2004, Vol 95, Num 5, pp 454-458, issn 1347-9032, 5 p.Article

OBSERVATION OF DIVIDING SPERMATOCYTES FOR CHROMOSOME. ABERRATIONS INDUCED IN MOUSE SPERMATOGONIA BY CHEMICAL MUTAGENS = OBSERVATION DES CHROMOSOMES DES SPERMATOCYTES EN DIVISION. ABERRATIONS INDUITES DANS LES SPERMATOGONIES DE SOURIS PAR DES MUTAGENES CHIMIQUESLEONARD A; LINDEN G.1972; MUTATION RES.; NETHERL.; DA. 1972; VOL. 16; NO 3; PP. 297-300; BIBL. 1P.1/2Serial Issue

BUSULPHAN AND THE LUNGS. ABSENCE OF LUNG FUNCTION DISTURBANCE IN PATIENTS TREATED WITH BUSULPHAN = BUSULPHAN ET LES POUMONS. ABSENCE DE TROUBLE DE LA FONCTION PULMONAIRE CHEZ DES MALADES TRAITES PAR LE BUSULPHANCOMHAIRE F; VANHOVE W; VAN GANSE W et al.1972; SCAND. J. RESP. DIS.; DENM.; DA. 1972; VOL. 53; NO 5; PP. 265-273; BIBL. 21REF.Serial Issue

UN CAS D'APLASIE MEDULLAIRE, A LA SUITE D'UNE PRISE UNIQUE D'UNE DOSE DE MYELOSANEMASLOV EN; GELENKO AM.1973; PROBL. GEMATOL. PERELIV. KROVI; S.S.S.R.; DA. 1973; VOL. 18; NO 1; PP. 59Serial Issue

Determination of Busulfan in Human Plasma Using an ELISA FormatCOURTNEY, Jodi B; HARNEY, Rebecca; SALAMONE, Salvatore J et al.Therapeutic drug monitoring. 2009, Vol 31, Num 4, pp 489-494, issn 0163-4356, 6 p.Article

Glutathione S-transferase Polymorphisms Are Not Associated With Population Pharmacokinetic Parameters of Busulfan in Pediatric PatientsZWAVELING, Juliette; PRESS, Rogier R; BREDIUS, Robbert G. M et al.Therapeutic drug monitoring. 2008, Vol 30, Num 4, pp 504-510, issn 0163-4356, 7 p.Article

Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patientsMUNKELT, Doreen; KOEHL, Ulrike; KLINGEBIEL, Thomas et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 821-830, issn 0344-5704, 10 p.Article

  • Page / 40